1-cyclopropyl-6-fluoro-8-hydroxy-4-oxo-7-((4aR,7aR)-tetrahydro-1H-pyrrolo[3,4-b]pyridin-6(2H,7H,7aH)-yl)-1,4-dihydroquinoline-3-carboxylic acid hydrobroMide
|
|
- CAS-Nr.
- 1292904-74-5
- Englisch Name:
- 1-cyclopropyl-6-fluoro-8-hydroxy-4-oxo-7-((4aR,7aR)-tetrahydro-1H-pyrrolo[3,4-b]pyridin-6(2H,7H,7aH)-yl)-1,4-dihydroquinoline-3-carboxylic acid hydrobroMide
- Synonyma:
- Moxifloxacin-5;Moxifloxacin EP Impurity E;Moxifloxacin HCl EP Impurity-E;Moxifloxacin EP Impurity E HBr;Azilsartan medoxomil impurity287;Moxifloxacin EP Impurity E Hydrobromide;Moxifloxacin Impurity 10(Moxifloxacin EP Impurity E HBr);1-cyclopropyl-6-fluoro-8-hydroxy-7-((4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid hydrobromide;1-Cyclopropyl-6-fluoro-8-hydroxy-7-((4aR,7aR)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid hydrobromide;1-cyclopropyl-6-fluoro-8-hydroxy-4-oxo-7-((4aR,7aR)-tetrahydro-1H-pyrrolo[3,4-b]pyridin-6(2H,7H,7aH)-yl)-1,4-dihydroquinoline-3-carboxylic acid hydrobroMide
- CBNumber:
- CB12605576
- Summenformel:
- C20H23BrFN3O4
- Molgewicht:
- 468.32
- MOL-Datei:
- 1292904-74-5.mol
|
1-cyclopropyl-6-fluoro-8-hydroxy-4-oxo-7-((4aR,7aR)-tetrahydro-1H-pyrrolo[3,4-b]pyridin-6(2H,7H,7aH)-yl)-1,4-dihydroquinoline-3-carboxylic acid hydrobroMide Eigenschaften
- L?slichkeit
- DMSO (Slightly), Methanol (Slightly, Sonicated), Water (Slightly)
- Aggregatzustand
- Solid
- Farbe
- Yellow
Sicherheit
1-cyclopropyl-6-fluoro-8-hydroxy-4-oxo-7-((4aR,7aR)-tetrahydro-1H-pyrrolo[3,4-b]pyridin-6(2H,7H,7aH)-yl)-1,4-dihydroquinoline-3-carboxylic acid hydrobroMide Chemische Eigenschaften,Einsatz,Produktion Methoden
Verwenden
8-Hydroxy Moxifloxacin Hydrobromide is a Moxifloxacin (M745000) impurity E.
1-cyclopropyl-6-fluoro-8-hydroxy-4-oxo-7-((4aR,7aR)-tetrahydro-1H-pyrrolo[3,4-b]pyridin-6(2H,7H,7aH)-yl)-1,4-dihydroquinoline-3-carboxylic acid hydrobroMide Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
1-cyclopropyl-6-fluoro-8-hydroxy-4-oxo-7-((4aR,7aR)-tetrahydro-1H-pyrrolo[3,4-b]pyridin-6(2H,7H,7aH)-yl)-1,4-dihydroquinoline-3-carboxylic acid hydrobroMide Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 40)Lieferanten
- 1-cyclopropyl-6-fluoro-8-hydroxy-4-oxo-7-((4aR,7aR)-tetrahydro-1H-pyrrolo[3,4-b]pyridin-6(2H,7H,7aH)-yl)-1,4-dihydroquinoline-3-carboxylic acid hydrobroMide
- Moxifloxacin EP Impurity E
- Moxifloxacin impurity 9/Moxifloxacin EP Impurity E HBr/8-Hydroxy Moxifloxacin HBr/1-Cyclopropyl-6-fluoro-1,4-dihydro-8-hydroxy-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic Acid Hydrobromide
- Moxifloxacin-5
- 1-cyclopropyl-6-fluoro-8-hydroxy-7-((4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid hydrobromide
- Azilsartan medoxomil impurity287
- 3-Quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-8-hydroxy-7-[(4aR,7aR)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-, hydrobromide (1:1), rel-
- 1-Cyclopropyl-6-fluoro-8-hydroxy-7-((4aR,7aR)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid hydrobromide
- Moxifloxacin Impurity 10(Moxifloxacin EP Impurity E HBr)
- Moxifloxacin EP Impurity E Hydrobromide
- Moxifloxacin HCl EP Impurity-E
- Moxifloxacin EP Impurity E HBr
- 1292904-74-5